BioBos Respi 3, suspension for injection for cattle
Inactivated vaccine against Bovine Respiratory Disease Complex.
|type of preparative:||Vaccines|
|target species animals:||Cattle|
Suspension for injection.
Rosy liquid with sediment.
Bovine respiratory syncytial virus (BRSV) inactivated, strain BiO-24 RP ≥ 1*
Bovine parainfluenza 3 virus inactivated (PI3V), strain Bio-23 RP ≥ 1*
Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1 RP ≥ 1*
*RP = Relative potency (ELISA) in comparison with the reference serum obtained after vaccination of guinea pigs with a vaccine batch that has successfully passed the challenge test in the target animals.
For active immunisation of cattle against:
bovine parainfluenza 3 virus, to reduce infection, bovine respiratory syncytial virus, to reduce infection and clinical signs, germs of Mannheimia (Pasteurella) haemolytica serotype A1, to reduce clinical signs and lung lesions.
Onset of immunity: 3 weeks.
Duration of immunity: 6 months.
Dosage, application and vaccination scheme
Vaccine dose – 2 ml. The vaccine is administered subcutaneously. Heat up the vaccine before use to a temperature of 15 to 25 °C and shake the content of the vial.
Calves from non-immunized cows: 2 dosis 3 weeks apart from 2 weeks of age.
Calves from immunized cows: 2 dosis 3 weeks apart from 3 months of age.
In problematic breeds, another revaccination is recommended within a period of 6 months after primovaccination, possibly before risky period in particular breed (e.g. transfer of animals, change of the stabling system, etc.).
Can be used during pregnancy and lactation.
Store in a refrigerator (2 °C–8 °C).
Protect from frost.
Protect from light.
Shelf-life of the veterinary medicinal product as packaged for sale: 2 years.
Shelf-life after first opening the immediate packaging: 10 hours.
10 ml, 50 ml, 100 ml in glass or plastic bottle.
Not all pack sizes may be marketed.